Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis.

Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis.

Item

http://www.wikidata.org/entity/Q45851521

Q45851521

about

Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Antithymocyte globulin in allogeneic hematopoietic cell transplantation: benefits and limitations.Lower dose anti-thymocyte globulin for GvHD prophylaxis results in improved survival after allogeneic stem cell transplantation.Effective prevention of GVHD using in vivo T-cell depletion with anti-lymphocyte globulin in HLA-identical or -mismatched sibling peripheral blood stem cell transplantation.In-vivo or ex-vivo T cell depletion or both to prevent graft-versus-host disease after hematopoietic stem cell transplantation.

P2860

Q37618811-DBF8CACC-56B3-4203-891D-8813E93C1310 Q38773356-C718F836-9A8D-411D-8C08-486FAE6B6E15 Q41134787-EF87A94C-55A9-4EB1-B4AF-2170D3E6DF39 Q46848879-234539BC-F713-446F-A311-4DA03D653E72 Q48680865-2FC05B37-62A6-4E4F-AE97-1DE91AB0DEDE

P2860

Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis.

Item

http://www.wikidata.org/entity/Q45851521

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Intensification of GVHD prophy ...... from a retrospective analysis.

@en

Intensification of GVHD prophy ...... from a retrospective analysis.

@nl

type

Item

label

Intensification of GVHD prophy ...... from a retrospective analysis.

@en

Intensification of GVHD prophy ...... from a retrospective analysis.

@nl

prefLabel

Intensification of GVHD prophy ...... from a retrospective analysis.

@en

Intensification of GVHD prophy ...... from a retrospective analysis.

@nl

P1476

Intensification of GVHD prophy ...... from a retrospective analysis.

@en

P2093

A Bontadini

http://www.w3.org/2001/XMLSchema#string

E Dan

http://www.w3.org/2001/XMLSchema#string

E Massari

http://www.w3.org/2001/XMLSchema#string

G Bandini

http://www.w3.org/2001/XMLSchema#string

G Tolomelli

http://www.w3.org/2001/XMLSchema#string

M Arpinati

http://www.w3.org/2001/XMLSchema#string

M Baccarani

http://www.w3.org/2001/XMLSchema#string

M R Motta

http://www.w3.org/2001/XMLSchema#string

P Pagliaro

http://www.w3.org/2001/XMLSchema#string

P Tazzari

http://www.w3.org/2001/XMLSchema#string

P2860

Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials.

Individual patient data meta-analysis of allogeneic peripheral blood stem cell transplant vs bone marrow transplant in the management of hematological malignancies: indirect assessment of the effect of day 11 methotrexate administration.

Changes in the use of hematopoietic stem cell transplantation: a model for diffusion of medical technology

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis.

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.

Allogeneic hematopoietic stem cell transplantation--yesterday, today, and tomorrow.

Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.

Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning.

P2888

bmt.2011.225

P304

1105-1111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2011.225

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Francesca Bonifazi

Marta Stanzani

P577

2011-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51815437

http://www.w3.org/2001/XMLSchema#string

P6179

1007906647

http://www.w3.org/2001/XMLSchema#string

P698

22101198

http://www.w3.org/2001/XMLSchema#string

P921

sibling

Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis.

about

P2860

P2860

Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P6179

P698

P921